Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00462059 · ClinicalTrials.gov registry record · NA
Assessment of a Medication Reconciliation Program on Transitional Care
A NA study of Hospitalization, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT00462059: Completed NA study of Hospitalization, sponsored by Kaiser Permanente.
NCT00462059 is a NA study of Hospitalization that has completed, run by Kaiser Permanente. The registered enrollment target is 200 participants, below the 487-participant average among 3 other Hospitalization trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00462059, a NA study of Hospitalization, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess and compare the effectiveness of the Kaiser Permanente Colorado's (KPCO) Call Center's Medication Reconciliation Program and standard care in regards to their impacts on emergency department (ED) and urgent care visits, inpatient rehospitalizations, and adherence to preferred, formulary medications.
Conditions Studied
Interventions
- BEHAVIORAL Treatment
Study Locations (1)
Colorado
- Kaiser-Permanente Colorado Region, Clinical Pharmacy Dept. - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-03 |
| Phase | NA |
What the finished NCT00462059 record still lists
NCT00462059 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 487-participant average among 3 other Hospitalization trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Hospitalization appearing as the primary indexed condition, and to 1 intervention - of which Treatment is the first listed.
NCT00462059 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT00462059 about?
NCT00462059 is a clinical study titled "Assessment of a Medication Reconciliation Program on Transitional Care". The purpose of this study is to assess and compare the effectiveness of the Kaiser Permanente Colorado's (KPCO) Call Center's Medication Reconciliation Program and standard care in regards to their impacts on emergency department (ED) and urgent care visits, inpatient rehospitalizations, and adheren...
What is the current status of trial NCT00462059?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2005-06. Estimated completion is 2007-03.
What conditions does trial NCT00462059 study?
This clinical trial studies the following conditions: Hospitalization.
What interventions are being tested in trial NCT00462059?
The interventions under investigation include: Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00462059?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00462059 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hospitalization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Patient Selected Visual Art in the Hospital Room During Antepartum Admission on Hospital Satisfaction Scores and Patient Experience
RECRUITING · NA
-
Vital Signs Reduction Study
ACTIVE NOT RECRUITING · NA
-
A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia